COHERUS ONCOLOGY INC (CHRS) — institutional ownership

157 funds reported holding COHERUS ONCOLOGY INC in their latest 13F filings, worth $111M in total (CUSIP 19249H103).

Largest holders

1. BlackRock, Inc. (BLK) — $16.8M
2. Timothy G. Youngquist 2020 Irrevocable Trust — $15.8M
3. VANGUARD GROUP INC — $14.2M
4. VANGUARD CAPITAL MANAGEMENT LLC — $8.33M
5. GEODE CAPITAL MANAGEMENT, LLC — $5.16M
6. Samsara BioCapital, LLC — $4.80M
7. Kohlberg Kravis Roberts & Co. L.P. — $4.18M
8. STATE STREET CORP (STT, STT-PG) — $3.34M
9. TWO SIGMA INVESTMENTS, LP — $3.16M
10. CM Management, LLC — $2.94M

Famous investors holding it

• Two Sigma portfolio (Two Sigma Investments)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Ken Griffin portfolio (Citadel Advisors)
• Izzy Englander portfolio (Millennium Management)

Insider buying and selling at COHERUS ONCOLOGY INC

Who owns the most CHRS stock?

The largest institutional holders in the latest 13F filings are BlackRock, Inc. (BLK) ($16.8M), Timothy G. Youngquist 2020 Irrevocable Trust ($15.8M), VANGUARD GROUP INC ($14.2M).

How many funds own CHRS?

157 funds reported holding it, worth $111M in total.